CDEK
← All organizations
Aeglea Biotherapeutics

Aeglea Biotherapeutics

For profitWebsite ↗

Also known as: Aeglea Biotherapeutics | Aeglea Biotherapeutics, Inc. | Aegle Therapeutics

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Oct 1, 2015

Last known activity

Apr 4, 2023

Acquired by Travere on Oct 23, 2020

Timeline

2010s

  1. Jun 1, 2013

    Aeglea Biotherapeutics— Founded

2020s

  1. Oct 23, 2020

    Travere— Acquired By

Drugs by trial phase (6 distinct, 10 trials)

Phase 3 (1 own, 0 via acquisition)

Phase 2 (3 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (17)

Details

Founded
Austin, TX, US Jun 1, 2013
Last known activity
Apr 4, 2023